MENU
DAWN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Day One Biopharmaceuticals (DAWN) Ownership - Who owns Day One Biopharmaceuticals?
Profile
Industry
N/A
Address
2000 Sierra Point Parkway
Phone
+1 650 484-0899
Employees
155
Web
https://www.dayonebio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.26B
P/E Ratio
N/A
Total Cash
558.38M
Projected Growth
N/A
Total Debt
2.62M
Revenue
101.95M
Risk (Beta)
-1.80
Dividend Yield
N/A
Total Cash/Share
5.54
Total Debt/Equity
N/A
Revenue/Share
1.14 USD as % of share price
Fundamentals
DAWN
Capitalization
1.26B
P/E Ratio
N/A
Risk (Beta)
-1.80
Dividend Yield
N/A
Total Cash
558M
Total Cash/Share
5.54
Total Debt
2.62M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.14%
Revenue
102M
ROE
N/A
Book Value
555M
P/B Ratio
2.27
Cash Flow
N/A
Earnings
-0.97
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10K
Current Ratio
14.62
Current Revenue Per Employee
538856.30
Dividends Per Share - Security
N/A
EBITDA
-210.08M
Float
N/A
Float - Current
N/A
Gross Income Margin
98.30
Revenue To Assets
-16.61
Shares Held By Institutions
1.69B
Shares Outstanding - Current
101M
Total Liabilities
45.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-13.425
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2000 Sierra Point Parkway
Phone
+1 650 484-0899
Employees
155
Web
https://www.dayonebio.com